Description
BAY 1895344 is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7nM. BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride